Passage Bio, Inc. Share Price
NASDAQ: PASG | Micro CapPassage Bio, Inc. Stock Performance
Passage Bio, Inc. Share Price Today
As of 18 November 2026, Passage Bio, Inc.'s share price is $4.17. The stock opened at $4.22, compared to its previous close of $3.98. During today's trading session, Passage Bio, Inc.'s share price traded between $4.22 and $4.22, with an average price of $4.22. Over the past 52 weeks, the stock has recorded a high of $19.81 and a low of $3.33. In terms of performance, Passage Bio, Inc.'s share price has declined by 26.84% over the last six months and is down 51.82% on a year-on-year basis.
Passage Bio, Inc. Share Price Chart
Passage Bio, Inc. Quarterly Profit & Loss
All figures in USD
Passage Bio, Inc. Annual Profit & Loss
All figures in USD
About Passage Bio, Inc.
Passage Bio Inc is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases. Their primary focus is the development and advancement of cutting-edge, one-time gene therapies designed to target critical underlying pathologies in these conditions. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target the critical underlying pathology of neurodegenerative diseases. The pipeline having PBFT02.
Passage Bio, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $3.55 | $4.22 | +12.67% |
Oct 2026 | $4.34 | $3.75 | -17.04% |
Sep 2026 | $4.71 | $4.52 | +1.12% |
Aug 2026 | $4.68 | $4.47 | +0.00% |
Jul 2026 | $4.92 | $4.47 | -8.21% |
Jun 2026 | $5.80 | $4.87 | -14.56% |
May 2026 | $5.00 | $5.70 | +14.23% |
Apr 2026 | $7.64 | $4.99 | -31.55% |
Mar 2026 | $8.63 | $7.29 | -19.71% |
Feb 2026 | $12.18 | $9.08 | -20.97% |
Jan 2026 | $11.82 | $11.49 | -1.37% |
Dec 2025 | $8.03 | $11.65 | +34.60% |